Clinical Trials
65 trialsOvAR-Y
Washington University School of Medicine
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
LONGEVITI
University of Alberta
iCaRe2
University of Nebraska
ELEPHAS-02
Elephas
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
SWOG Cancer Research Network
TraveraRTGx
Travera Inc
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
ASAP
Avera McKennan Hospital & University Health Center
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Carevive Systems, Inc.
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
EXoPERT EMERALD Clinical Study
EXoPERT
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
CCANED-CIPHER
Dysplasia Diagnostics Limited
LIBERATE
University Health Network, Toronto
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Dana-Farber Cancer Institute
PRIORITY
Institut Bergonié
START
Lyell Immunopharma, Inc.
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
Yonsei University
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
PREFER
Labcorp Corporation of America Holdings, Inc
INSPIRE
Singlera Genomics Inc.
MOHCCN-O
University Health Network, Toronto
ROOT
Taproot Health
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
QUANTUM
VitaMed Research LLC
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
National Institutes of Health Clinical Center (CC)
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
MORRIS
Umeå University
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Biologics & Biosimilars Collective Intelligence Consortium
ELISA
Assistance Publique - Hôpitaux de Paris
Establishment of a Tumor Bank for Blood Samples
Medical University of Vienna
Establishment of a Tumor Bank for Tissue Samples
Medical University of Vienna
Guangzhou Women's Health Cohort Study (GWHCS)
Guangzhou Women and Children's Medical Center
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Exact Sciences Corporation
Taiwan Cancer Moonshot Project
Academia Sinica, Taiwan
Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory
Kazakh Medical University of Continuing Education
SPACE2
Weprom
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
TScan Therapeutics, Inc.